IOVANCE BIOTHERAPEUTICS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Carlos, CA
SEC filing record 1 source field available
Fiscal year end
31 December
IOVANCE BIOTHERAPEUTICS, INC. has filed 1,025 SEC EDGAR filings since 29 Jan 2008

SEC filing history

Showing 576-600 of 998 matching filings.

Per page
25
Current page
24
POS AM File 333-212373

POS AM

Filing date
31 Jul 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-214073

POS AM

Filing date
31 Jul 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-217638

S-8 POS

Filing date
31 Jul 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-214567

S-8 POS

Filing date
31 Jul 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36860

FORM 8-K

Filing date
27 Jul 2017
Reporting date
22 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-A12B/A File 001-36860

8-A12B/A

Filing date
27 Jul 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36860

8-K

Filing date
27 Jun 2017
Reporting date
27 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Jun 2017
Reporting date
01 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Jun 2017
Reporting date
01 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Jun 2017
Reporting date
01 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Jun 2017
Reporting date
01 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Jun 2017
Reporting date
01 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36860

FORM 8-K

Filing date
05 Jun 2017
Reporting date
05 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36860

FORM 8-K

Filing date
02 Jun 2017
Reporting date
01 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36860

FORM 8-K

Filing date
25 May 2017
Reporting date
22 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-85384

SC 13G/A filing

Filing date
09 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-217638

S-8

Filing date
03 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36860

FORM 8-K

Filing date
01 May 2017
Reporting date
28 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36860

FORM 8-K

Filing date
21 Apr 2017
Reporting date
20 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36860

DEFA14A

Filing date
20 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36860

DEF 14A

Filing date
20 Apr 2017
Reporting date
01 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36860

FORM 8-K

Filing date
19 Apr 2017
Reporting date
17 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36860

FORM 8-K

Filing date
11 Apr 2017
Reporting date
10 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-36860

PRE 14A

Filing date
06 Apr 2017
Reporting date
06 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .